{
    "organizations": [],
    "uuid": "a44308828e67c8233d0ef08c1bba2a9d9e7159f7",
    "author": "",
    "url": "https://www.reuters.com/article/brief-aveo-pharmaceuticals-entered-into/brief-aveo-pharmaceuticals-entered-into-sales-agreement-with-leerink-partners-idUSFWN1Q61DE",
    "ord_in_thread": 0,
    "title": "BRIEF-Aveo Pharmaceuticals ‍Entered Into Sales Agreement With Leerink Partners",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 16 PM / Updated 11 minutes ago BRIEF-Aveo Pharmaceuticals ‍Entered Into Sales Agreement With Leerink Partners Reuters Staff Feb 16 (Reuters) - Aveo Pharmaceuticals Inc: * AVEO PHARMACEUTICALS SAYS ‍ENTERED INTO A SALES AGREEMENT WITH LEERINK PARTNERS - SEC FILING * AVEO PHARMACEUTICALS - ‍PURSUANT TO AGREEMENT, CO MAY ISSUE, SELL SHARES OF COMMON STOCK, $0.001 PAR VALUE PER SHARE FROM TIME TO TIME THROUGH LEERINK​ Source text: ( bit.ly/2oaeRKo )  ",
    "published": "2018-02-16T23:13:00.000+02:00",
    "crawled": "2018-02-16T23:35:41.029+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "pharmaceutical",
        "sale",
        "agreement",
        "leerink",
        "partner",
        "reuters",
        "staff",
        "feb",
        "reuters",
        "aveo",
        "pharmaceutical",
        "inc",
        "aveo",
        "pharmaceutical",
        "say",
        "sale",
        "agreement",
        "leerink",
        "partner",
        "sec",
        "filing",
        "aveo",
        "pharmaceutical",
        "agreement",
        "co",
        "may",
        "issue",
        "sell",
        "share",
        "common",
        "stock",
        "par",
        "value",
        "per",
        "share",
        "time",
        "time",
        "source",
        "text"
    ]
}